Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia, Myeloid, Acute 2Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Hematologic Neoplasms 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Sorafenib 3selpercatinib 2cabozantinib 2Thyroid (USP) 2Sodium 2Radiofrequency Ablation 2Metformin 2vandetanib 1tomivosertib 1temsirolimus 1repotrectinib 1pralsetinib 1pembrolizumab 1lenvatinib 1binimetinib 1apatinib 1acetaminophen, codeine drug combination 1Vitamin B 12 1Tramadol 1Thyroxine 1Thyrotropin-Releasing Hormone 1Technetium Tc 99m Sestamibi 1Surgical Procedures, Operative 1Pemetrexed 1Panobinostat 1Negative-Pressure Wound Therapy 1NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1Lysine Acetyltransferase 5 1Iodine-131 1Folic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thyroid Diseases × Blood Cell Count × Clear all
NCT04425512 2020-06-11

Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy

Kahramanmaras Sutcu Imam University

Phase NA Completed
333 enrolled
Head & Neck

Thyroid Diseases, Thyroid Neoplasms, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡